SEP 7, 2026 · JOURNAL ARTICLE
Predicting acquired T790M mutations in non-small cell lung cancer after EGFR-TKI therapy: integration of delta-radiomics and clinical characteristics with SHAP interpretation
BMC Medical Imaging
Retrospective, single-centre study with modest sample size and surrogate endpoint (mutation status prediction); requires prospective multicentre validation before clinical use, as stated by the authors.
Reported
Test set AUC – combined model0.82
Test set AUC – clinical model0.70
Test set AUC – NECT radiomics mod…0.63